admin

The Central Executive Meeting in Lahore focused on advancing PPMA’s mission of ensuring quality, affordable, and globally competitive medicines.

Citi Pharma and China’s Xin Weisheng are establishing a fully automated antibiotic plant by 2026, producing key APIs and lifesaving antibiotics. This step reduces import reliance and supports PPMA’s vision of self-reliance and affordable, quality medicines in Pakistan.

ATCO Pharma has become Pakistan’s first and only pharmaceutical company with a PIC/S-compliant sterile facility. This milestone ensures safer medicines for patients while strengthening Pakistan’s global pharmaceutical standing and export potential.

The 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐢𝐩𝐥𝐨𝐦𝐚 𝐂𝐨𝐮𝐫𝐬𝐞 𝐂𝐨𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐂𝐞𝐫𝐞𝐦𝐨𝐧𝐲 was held at DUHS, attended by 𝐏𝐏𝐌𝐀 𝐂𝐡𝐚𝐢𝐫𝐦𝐚𝐧 𝐌𝐫. 𝐓𝐨𝐮𝐪𝐞𝐞𝐫 𝐮𝐥 𝐇𝐚𝐪, 𝐏𝐏𝐌𝐀 𝐬𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬, and industry experts. Faculty including 𝐃𝐫. 𝐒𝐚𝐢𝐟 𝐮𝐫 𝐑𝐚𝐡𝐦𝐚𝐧, 𝐌𝐫. 𝐒𝐮𝐥𝐭𝐚𝐧 𝐆𝐡𝐚𝐧𝐢, 𝐃𝐫. 𝐑𝐢𝐦𝐚 𝐈𝐬𝐡𝐚𝐪, 𝐃𝐫. 𝐒𝐡𝐚𝐡𝐧𝐚𝐰𝐚𝐳 𝐒𝐚𝐣𝐢𝐝, 𝐌𝐫. 𝐌𝐮𝐣𝐚𝐡𝐢𝐝, 𝐌𝐫. 𝐑𝐚𝐬𝐡𝐢𝐝 𝐌𝐮𝐫𝐞𝐞𝐝, and 𝐌𝐫. 𝐇𝐚𝐧𝐢𝐟 𝐀𝐣𝐚𝐫𝐢 were honoured, while graduating students proudly received

PMA delegates held an important meeting with: • Minister Health, 𝐒𝐲𝐞𝐝 𝐌𝐮𝐬𝐭𝐚𝐟𝐚 𝐊𝐚𝐦𝐚𝐥 • Federal Secretary NHS, 𝐌𝐫. 𝐇𝐚𝐦𝐞𝐝 𝐘𝐚𝐪𝐨𝐨𝐛 𝐒𝐡𝐞𝐢𝐤𝐡 • CEO DRAP, 𝐃𝐫. 𝐎𝐛𝐚𝐢𝐝 𝐔𝐥𝐥𝐚𝐡 The discussion focused on strengthening partnerships, addressing key industry challenges, and working together for the advancement of Pakistan’s healthcare sector.

With a steady 𝟏𝟎% 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞, the pharmaceutical sector continues to showcase resilience, innovation, and its vital role in strengthening healthcare access across the nation.

PPMA North Chairman Saad Javed Akram met Mr. Tahir Habib Cheema (Collector of Customs) for a constructive discussion on industry challenges and growth opportunities.

DRAP & SECP sign MoU for eService Portal integration. Signed by Dr. Obaidullah (CEO, DRAP) & Mr. Muzzafar Ahmed Mirza (Commissioner, SECP). Witnessed by Mr. Qaiser Ahmed Sheikh (Federal Minister & Chairman BOI).

DRAP has issued a rapid alert against falsified drug products, with spurious batches seized. PPMA supports this action to safeguard public health and ensure safe, quality medicines for all.

With evolving US tariffs, Pakistan’s pharmaceutical industry is well-positioned to capture larger market share, reinforcing its reputation for quality and affordability.